|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
78
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR
|
|
1
|
71
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum
|
|
1
|
72
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
78
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
67
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, surgically treatment
|
|
1
|
67
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR
|
|
1
|
69
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
62
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
63
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR, surgically treated
|
|
1
|
60
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
73
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon oncological treatment, no surgery
|
|
1
|
71
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon surgical treatment
|
|
1
|
74
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, no surgery or oncological treatment
|
|
1
|
64
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR
|
|
1
|
60
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, oncological treatment no surgery
|
|
1
|
69
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
74
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
69
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no curative surgery
|
|
1
|
66
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, treated with curative intended surgery
|
|
1
|
68
|
September 18, 2023
|
|
Phenotype submission: Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery and oncological treatment
|
|
1
|
68
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma cancer reciving surgical treatment
|
|
1
|
76
|
September 18, 2023
|
|
Phenotype submission - local recurrence following colorectal cancer
|
|
1
|
68
|
September 18, 2023
|
|
Phenotype submission - Postoperative hemorrhage
|
|
1
|
78
|
September 18, 2023
|
|
Phenotype submission - Perioperative aspiration
|
|
1
|
72
|
September 18, 2023
|
|
Phenotype submission - Anastomotic leak or dehiscence following colorectal surgery
|
|
1
|
73
|
September 18, 2023
|
|
Phenotype submission - Fascial dehiscence and evisceration
|
|
1
|
99
|
September 18, 2023
|
